Received Jun 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | W025817 | — |
No additional AE/No PQC.; HCP calling to report expired administration of RECOMBIVAX HB on 06/02/2025. The product was expired on 05/21/2025 with no TEs. No symptoms reported on behalf of patient. Supported outcome delivered verbally per memo. Received consent to contact. No; This spontaneous report was received from a physician and refers to a 10-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-JUN-2025, the patient was vaccinated with an expired vaccine of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (valid lot number W025817, expiration date: 21-MAY-2025) for prophylaxis (dose, dose number, frequency, anatomical location and route of administration were not provided) (expired product administration), no temperature excursion were reported. No symptoms reported on behalf of patient. No additional adverse event (AE) reported.